File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia

TitleUse of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia
Authors
KeywordsHRQOL
validity
reliability
IPSS
Chinese
benign prostatic hyperplasia
Issue Date2017
PublisherTaylor & Francis. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/13685538.asp
Citation
The Aging Male, 2017, v. 20 n. 4, p. 241-249 How to Cite?
AbstractPurpose: To test the psychometric properties of the International Prostate Symptom Score (Hong Kong Chinese version 2) (IPSS) in Chinese male patients with benign prostatic hyperplasia (BPH) under secondary care. Methods: A prospective longitudinal study was done by interviewing subjects at baseline, at 2 week after baseline for assessing test–retest reliability and at 26 week after baseline for assessing responsiveness. All subjects were interviewed to complete a structured questionnaire including IPSS, Short Form-12 Health Survey version 2 (SF-12v2) and Depression Anxiety Stress Scale (DASS). Results: The IPSS HRQOL score had weak correlations with SF-12v2 summary and DASS domain scores. For reliability analysis, Cronbach’s alpha coefficient was 0.90 for the seven symptom-related items. The intraclass correlation coefficients of the IPSS total symptom score and HRQOL score were 0.90 and 0.86, respectively. For sensitivity, statistically significant differences were detected between the subjects with BPH and those without for IPSS total symptom score (effect size=0.68) but not the IPSS HRQOL score. The areas under ROC curves for the IPSS total symptom and HRQOL scores were 0.67 and 0.60, respectively. Conclusions: The IPSS was valid, reliable instrument in Chinese patients with BPH. The IPSS total symptom score, but not the HRQOL score, is sensitive in differentiating subgroups.
Persistent Identifierhttp://hdl.handle.net/10722/243156
ISSN
2017 Impact Factor: 2.5
2015 SCImago Journal Rankings: 0.477
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorChoi, PH-
dc.contributor.authorChan, SWH-
dc.contributor.authorTsu, HLJ-
dc.contributor.authorFan, CW-
dc.contributor.authorChu, SK-
dc.contributor.authorCheung, FK-
dc.contributor.authorMa, WK-
dc.contributor.authorMah, ISF-
dc.contributor.authorYip, SKH-
dc.contributor.authorHou, SSM-
dc.contributor.authorSo, HS-
dc.contributor.authorLam, CLK-
dc.date.accessioned2017-08-25T02:50:49Z-
dc.date.available2017-08-25T02:50:49Z-
dc.date.issued2017-
dc.identifier.citationThe Aging Male, 2017, v. 20 n. 4, p. 241-249-
dc.identifier.issn1368-5538-
dc.identifier.urihttp://hdl.handle.net/10722/243156-
dc.description.abstractPurpose: To test the psychometric properties of the International Prostate Symptom Score (Hong Kong Chinese version 2) (IPSS) in Chinese male patients with benign prostatic hyperplasia (BPH) under secondary care. Methods: A prospective longitudinal study was done by interviewing subjects at baseline, at 2 week after baseline for assessing test–retest reliability and at 26 week after baseline for assessing responsiveness. All subjects were interviewed to complete a structured questionnaire including IPSS, Short Form-12 Health Survey version 2 (SF-12v2) and Depression Anxiety Stress Scale (DASS). Results: The IPSS HRQOL score had weak correlations with SF-12v2 summary and DASS domain scores. For reliability analysis, Cronbach’s alpha coefficient was 0.90 for the seven symptom-related items. The intraclass correlation coefficients of the IPSS total symptom score and HRQOL score were 0.90 and 0.86, respectively. For sensitivity, statistically significant differences were detected between the subjects with BPH and those without for IPSS total symptom score (effect size=0.68) but not the IPSS HRQOL score. The areas under ROC curves for the IPSS total symptom and HRQOL scores were 0.67 and 0.60, respectively. Conclusions: The IPSS was valid, reliable instrument in Chinese patients with BPH. The IPSS total symptom score, but not the HRQOL score, is sensitive in differentiating subgroups.-
dc.languageeng-
dc.publisherTaylor & Francis. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/13685538.asp-
dc.relation.ispartofThe Aging Male-
dc.rightsThis is an electronic version of an article published in The Aging Male, 2017, v. 20 n. 4, p. 241-249. The Aging Male is available online at: https://www.tandfonline.com/doi/full/10.1080/13685538.2017.1362380-
dc.subjectHRQOL-
dc.subjectvalidity-
dc.subjectreliability-
dc.subjectIPSS-
dc.subjectChinese-
dc.subjectbenign prostatic hyperplasia-
dc.titleUse of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia-
dc.typeArticle-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailChoi, PH: h0714919@connect.hku.hk-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.identifier.emailFan, CW: fancwdoc@hku.hk-
dc.identifier.emailMa, WK: mwk054@hku.hk-
dc.identifier.emailLam, CLK: clklam@hku.hk-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityChoi, PH=rp02329-
dc.identifier.authorityLam, CLK=rp00350-
dc.description.naturepostprint-
dc.identifier.doi10.1080/13685538.2017.1362380-
dc.identifier.scopuseid_2-s2.0-85027023678-
dc.identifier.hkuros274890-
dc.identifier.volume20-
dc.identifier.issue4-
dc.identifier.spage241-
dc.identifier.epage249-
dc.identifier.isiWOS:000414914800005-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats